Havglo 600mg Injection contains Glutathione 600mg as its active ingredient and is indicated for use as an antioxidant and detoxifying agent in various clinical conditions. Glutathione is a tripeptide composed of glutamine, cysteine, and glycine, playing a critical role in cellular protection against oxidative stress by neutralizing free radicals and reactive oxygen species. This injectable formulation is primarily utilized in the management of liver disorders, including acute and chronic hepatitis, cirrhosis, and fatty liver disease, to enhance hepatic function and promote detoxification. Additionally, Havglo 600mg Injection may be employed as an adjunct therapy in the treatment of certain neurodegenerative diseases and to mitigate the adverse effects of chemotherapy and radiotherapy by reducing oxidative damage. The administration of this injection should be performed under medical supervision, with dosage and duration tailored according to the patient’s clinical condition and response to therapy. Common precautions include monitoring for hypersensitivity reactions and ensuring compatibility with concurrent medications. Havglo 600mg Injection is contraindicated in patients with known hypersensitivity to glutathione or any of its excipients. Proper storage conditions should be maintained to preserve the stability and efficacy of the product.